Future of AIDS Gels May Lie in Drugs, Experts Say
March 8, 2010
Research presented at the 17th Conference on Retroviruses and Opportunistic Infections indicates a new class of antiretroviral drugs called CCR5 entry inhibitors could be used to produce an effective microbicide against HIV. The drugs block HIV from entering human cells using a type of cellular doorway or receptor named CCR5.
Dr. John Moore, of Weill Cornell Medical College, and colleagues tested the CCR5 inhibitor maraviroc, a Pfizer drug sold under the brand name Selzentry. Tests in monkeys showed a candidate microbicide containing the drug would protect a female from sexual HIV transmission for about four hours.
02.19.2010; Maggie Fox
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.